| The immune subtypes and landscape of squamous cell carcinoma B Li, Y Cui, DK Nambiar, JB Sunwoo, R Li Clinical Cancer Research 25 (12), 3528-3537, 2019 | 171 | 2019 |
| Usnic acid inhibits growth and induces cell cycle arrest and apoptosis in human lung carcinoma A549 cells N Singh, D Nambiar, RK Kale, RP Singh Nutrition and cancer 65 (sup1), 36-43, 2013 | 139 | 2013 |
| Galectin-1–driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance DK Nambiar, T Aguilera, H Cao, S Kwok, C Kong, J Bloomstein, Z Wang, ... The Journal of clinical investigation 129 (12), 5553-5567, 2019 | 137 | 2019 |
| Effects of phytochemicals on ionization radiation-mediated carcinogenesis and cancer therapy D Nambiar, P Rajamani, RP Singh Mutation Research/Reviews in Mutation Research 728 (3), 139-157, 2011 | 127 | 2011 |
| Hypoxia induces triglycerides accumulation in prostate cancer cells and extracellular vesicles supporting growth and invasiveness following reoxygenation IR Schlaepfer, DK Nambiar, A Ramteke, R Kumar, D Dhar, C Agarwal, ... Oncotarget 6 (26), 22836, 2015 | 107 | 2015 |
| Fisetin inhibits various attributes of angiogenesis in vitro and in vivo —implications for angioprevention TA Bhat, D Nambiar, A Pal, R Agarwal, RP Singh Carcinogenesis 33 (2), 385-393, 2012 | 105 | 2012 |
| Chemical space mimicry for drug discovery W Yuan, D Jiang, DK Nambiar, LP Liew, MP Hay, J Bloomstein, P Lu, ... Journal of chemical information and modeling 57 (4), 875-882, 2017 | 100 | 2017 |
| Acacetin Inhibits In Vitro and In Vivo Angiogenesis and Downregulates Stat Signaling and VEGF Expression TA Bhat, D Nambiar, D Tailor, A Pal, R Agarwal, RP Singh Cancer Prevention Research 6 (10), 1128-1139, 2013 | 78 | 2013 |
| In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells D Nambiar, V Prajapati, R Agarwal, RP Singh Cancer letters 334 (1), 109-117, 2013 | 72 | 2013 |
| Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element … DK Nambiar, G Deep, RP Singh, C Agarwal, R Agarwal Oncotarget 5 (20), 10017, 2014 | 65 | 2014 |
| Silibinin inhibits hypoxia‐induced HIF‐1α‐mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: in vitro evidence and in vivo functional imaging and … G Deep, R Kumar, DK Nambiar, AK Jain, AM Ramteke, NJ Serkova, ... Molecular carcinogenesis 56 (3), 833-848, 2017 | 63 | 2017 |
| Silibinin attenuates ionizing radiation-induced pro-angiogenic response and EMT in prostate cancer cells DK Nambiar, P Rajamani, RP Singh Biochemical and biophysical research communications 456 (1), 262-268, 2015 | 53 | 2015 |
| Silibinin preferentially radiosensitizes prostate cancer by inhibiting DNA repair signaling DK Nambiar, P Rajamani, G Deep, AK Jain, R Agarwal, RP Singh Molecular cancer therapeutics 14 (12), 2722-2734, 2015 | 48 | 2015 |
| Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer D Tailor, A Resendez, FJ Garcia-Marques, M Pandrala, CC Going, ... Cell Chemical Biology 28 (8), 1206-1220. e6, 2021 | 40 | 2021 |
| NFE2L2 Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells L Guan, DK Nambiar, H Cao, V Viswanathan, S Kwok, AB Hui, Y Hou, ... Cancer research 83 (6), 861-874, 2023 | 31 | 2023 |
| Targeting DNA repair for cancer treatment: Lessons from PARP inhibitor trials DK Nambiar, D Mishra, RP Singh Oncology research 31 (4), 405, 2023 | 30 | 2023 |
| Aldehyde dehydrogenase 3A1 activation prevents radiation-induced xerostomia by protecting salivary stem cells from toxic aldehydes JP Saiki, H Cao, LD Van Wassenhove, V Viswanathan, J Bloomstein, ... Proceedings of the National Academy of Sciences 115 (24), 6279-6284, 2018 | 26 | 2018 |
| Advances in prostate cancer chemoprevention: a translational perspective D Nambiar, RP Singh Nutrition and cancer 65 (sup1), 12-25, 2013 | 26 | 2013 |
| Novel Aza-podophyllotoxin derivative induces oxidative phosphorylation and cell death via AMPK activation in triple-negative breast cancer D Tailor, CC Going, A Resendez, V Kumar, DK Nambiar, Y Li, A Dheeraj, ... British Journal of Cancer 124 (3), 604-615, 2021 | 19 | 2021 |
| The combination of radiotherapy and complement C3a inhibition potentiates natural killer cell functions against pancreatic cancer QH Sodji, DK Nambiar, V Viswanathan, R von Eyben, D Colburg, ... Cancer research communications 2 (7), 725-738, 2022 | 13 | 2022 |
